Skip Content
ADE Banner

ADE: Adverse Drug Events

Why We Want to Prevent ADE

Adverse drug events are injuries stemming from medication use. Adverse drug events occur in vast numbers every year in both inpatient and outpatient settings. ADEs cause more than 770,000 deaths per year.

According to the Office of Disease Prevention and Health Promotion, ADEs affect around 2 million hospital stays every year and account for roughly 33 percent of all adverse events in a hospital setting. ADEs make up the largest category of adverse events experienced by patients in a hospital setting. In an outpatient setting, ADEs involve 1 million visits to the emergency department and more than 100,000 hospital admissions.

ADEs are preventable in both settings. ADEs lead to increased morbidity and mortality, prolonged hospitalizations and higher costs. A 2007 report found that between 380,000 and 450,000 preventable ADEs occurred in United States hospitals.

NJHIIN is focusing on three high-risk classes of medications in order to reduce adverse drug events: opioids (pain killers), anticoagulants (blood thinners) and hypoglycemic (lower blood sugars).

Success Within New Jersey Hospitals

Compared to baseline, New Jersey's hospitals have reduced ADEs by 55 percent, avoided 3,122 potential ADEs and saved $9,367,446 in unnecessary healthcare costs.

Our Goals Moving Ahead

By September 2018, each participating NJHIIN hospital will reduce ADEs by at least 20 percent or sustain a rate of zero.


NJHIIN Webinars

NJHIIN Opioid Stewardship 101 Series

Other NJHIIN Webinars